Emmett V. Schmidt

Overview

Best Publications

• Mammary Hyperplasia and Carcinoma in MMTV-cyclin D1 Transgenic Mice

  Timothy C. Wang;Robert D. Cardiff;Lawrence Zukerberg;Emma Lees

  1232
  Citations

• IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development

  Yixue Cao;Giuseppina Bonizzi;Tiffany N. Seagroves;Florian R. Greten

  611
  Citations

• The role of c-myc in cellular growth control.

  Emmett V Schmidt

  540
  Citations

• Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial.

  Vicky Makker;Drew Rasco;Nicholas J Vogelzang;Marcia S Brose

  441
  Citations

• Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

  Vicky Makker;Matthew H. Taylor;Carol Aghajanian;Ana Oaknin

  412
  Citations

• Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E

  I B Rosenwald;A Lazaris-Karatzas;N Sonenberg;E V Schmidt

  363
  Citations

• Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc

  Igor B. Rosenwald;David B. Rhoads;Lawrence D. Callanan;Kurt J. Isselbacher

  359
  Citations

• Eukaryotic Translation Initiation Factor 4E Regulates Expression of Cyclin D1 at Transcriptional and Post-transcriptional Levels

  Igor B. Rosenwald;Roger Kaspar;Dennis Rousseau;Lee Gehrke

  338
  Citations

• Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells.

  Goshi Shiota;David B. Rhoads;Timothy C. Wang;Toshikazu Nakamura

  336
  Citations

• SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

  Antoni Ribas;Theresa Medina;Shivaani Kummar;Asim Amin

  333
  Citations

• The cytomegalovirus enhancer: a pan-active control element in transgenic mice.

  E V Schmidt;G Christoph;R Zeller;P Leder

  330
  Citations

• Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)

  Tara C Mitchell;Omid Hamid;David C Smith;Todd M Bauer

  320
  Citations

• Coupling of cell division to cell growth by translational control of the G1 cyclin CLN3 in yeast

  Michael Polymenis;Emmett V. Schmidt

  296
  Citations

• Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 (enkephalinase): direct evidence by cDNA transfection analysis

  Margaret A. Shipp;Jayanthi Vijayaraghavan;Emmett V. Schmidt;Emma L. Masteller

  267
  Citations

• Viral RNA Mutations Are Region Specific and Increased by Ribavirin in a Full-Length Hepatitis C Virus Replication System

  Ana Maria Contreras;Yoichi Hiasa;Wenping He;Adam Terella

  266
  Citations

• An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc.

  R M Jones;J Branda;K A Johnston;M Polymenis

  243
  Citations

• Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice

  Yasuo Imanishi;Yoshitaka Hosokawa;Katsuhiko Yoshimoto;Katsuhiko Yoshimoto;Ernestina Schipani

  234
  Citations

• The role of c-myc in regulation of translation initiation.

  Emmett V Schmidt

  225
  Citations

• Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors.

  Anthony W. Tolcher;Mario Sznol;Siwen Hu-Lieskovan;Kyriakos P. Papadopoulos

  208
  Citations

• Hepatitis C Virus Expression Suppresses Interferon Signaling by Degrading STAT1

  Wenyu Lin;Won Hyeok Choe;Yoichi Hiasa;Yoshitaka Kamegaya

  202
  Citations